Alyeska reports 9.73% stake in Exyn Technologies
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh report beneficial ownership of 774,000 shares of Exyn Technologies, Inc. common stock on a Schedule 13G. This represents 9.73% of the outstanding common stock as of June 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh report beneficial ownership of 774,000 shares of Exyn Technologies, Inc. common stock on a Schedule 13G. This represents 9.73% of the outstanding common stock as of June 30, 2026.
The reported position consists of 387,000 common shares and 387,000 shares issuable upon exercise of warrants. All voting and dispositive power over these securities is held on a shared basis, with no sole voting or dispositive power reported for any of the filing persons.
Key Figures
Key Terms
beneficially own financial
warrants financial
Schedule 13G regulatory
disclaims beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of EXYN common stock does Alyeska report owning?
Who has voting and dispositive power over Alyeska’s EXYN position?
What role does Anand Parekh have in the EXYN ownership reported on Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.